AU2001229712A1 - Reduction of hair growth - Google Patents

Reduction of hair growth

Info

Publication number
AU2001229712A1
AU2001229712A1 AU2001229712A AU2971201A AU2001229712A1 AU 2001229712 A1 AU2001229712 A1 AU 2001229712A1 AU 2001229712 A AU2001229712 A AU 2001229712A AU 2971201 A AU2971201 A AU 2971201A AU 2001229712 A1 AU2001229712 A1 AU 2001229712A1
Authority
AU
Australia
Prior art keywords
reduction
hair growth
hair
growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001229712A
Inventor
Gurpreet S Ahluwalia
Peter Styczynski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gillette Co LLC
Original Assignee
Gillette Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gillette Co LLC filed Critical Gillette Co LLC
Publication of AU2001229712A1 publication Critical patent/AU2001229712A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001229712A 2000-01-25 2001-01-23 Reduction of hair growth Abandoned AU2001229712A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/490,486 US6235737B1 (en) 2000-01-25 2000-01-25 Reduction of hair growth
US09490486 2000-01-25
PCT/US2001/002173 WO2001054654A2 (en) 2000-01-25 2001-01-23 Reduction of hair growth

Publications (1)

Publication Number Publication Date
AU2001229712A1 true AU2001229712A1 (en) 2001-08-07

Family

ID=23948266

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001229712A Abandoned AU2001229712A1 (en) 2000-01-25 2001-01-23 Reduction of hair growth

Country Status (10)

Country Link
US (1) US6235737B1 (en)
EP (1) EP1250119B1 (en)
AR (1) AR028498A1 (en)
AT (1) ATE374643T1 (en)
AU (1) AU2001229712A1 (en)
CA (1) CA2385006C (en)
DE (1) DE60130735T2 (en)
ES (1) ES2290151T3 (en)
MX (1) MXPA02005091A (en)
WO (1) WO2001054654A2 (en)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3973748B2 (en) 1998-01-14 2007-09-12 花王株式会社 Hair growth inhibitor
US7432302B2 (en) * 2001-01-08 2008-10-07 Mediquest Therapeutics, Inc. Composition containing polyamine transport inhibitor and use thereof
USRE43327E1 (en) 2001-01-08 2012-04-24 Aminex Therapeutics, Inc. Hydrophobic polyamine analogs and methods for their use
US7439271B2 (en) 2001-06-27 2008-10-21 The Gillette Company Reduction of hair growth
AU2002320470A1 (en) * 2001-07-11 2003-01-29 Musc Foundation For Research Development Modulators of ceramidase and methods of use based thereon
US7261878B2 (en) * 2001-08-10 2007-08-28 The Gillette Company Reduction of hair growth
US6743822B2 (en) 2001-08-10 2004-06-01 The Gillette Company Reduction of hair growth
US20030036561A1 (en) * 2001-08-10 2003-02-20 Peter Styczynski Reduction of hair growth
EP1287815A1 (en) * 2001-08-31 2003-03-05 Cosmoferm B.V. Use of a sphingoid base for inhibiting ceramidase activity
US6869519B2 (en) * 2001-09-27 2005-03-22 National Institute Of Advanced Industrial Science And Technology Electrolytic process for the production of metallic copper and apparatus therefor
US7160921B2 (en) * 2002-01-29 2007-01-09 The Gillette Company Reduction of hair growth
US20040198821A1 (en) * 2002-01-29 2004-10-07 Hwang Cheng Shine Reduction of hair growth
DE10214506A1 (en) * 2002-04-02 2003-10-16 Beiersdorf Ag Use of deoxynojirimycin and its derivatives for the treatment and prophylaxis of degenerative skin conditions
US20030199584A1 (en) * 2002-04-11 2003-10-23 Ahluwalia Gurpreet S. Reduction of hair growth
US7585518B2 (en) * 2002-11-19 2009-09-08 Kimberly-Clark Worldwide, Inc. Products and methods for maintaining or increasing ceramide levels in skin
US7037535B2 (en) * 2002-11-19 2006-05-02 Kimberly-Clark Worldwide, Inc. Method and composition for neutralizing house dust mite feces
US20040141935A1 (en) * 2003-01-21 2004-07-22 Peter Styczynski Reduction of hair growth
US7015349B2 (en) * 2003-03-26 2006-03-21 The Gillette Company Reduction of hair growth
US20050019379A1 (en) 2003-07-22 2005-01-27 Kimberly-Clark Worldwide, Inc. Wipe and methods for improving skin health
EP1680112B1 (en) * 2003-10-29 2010-12-15 Genzyme Corporation N-(5-adamantane-1-yl-methoxy-pentyl)deoxynojirimycin or a pharmaceutically salt thereof for use in the treatment of insulin resistance
EP1528056A1 (en) * 2003-10-29 2005-05-04 Academisch Ziekenhuis bij de Universiteit van Amsterdam Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors
US20050112075A1 (en) * 2003-11-25 2005-05-26 Hwang Cheng S. Reduction of hair growth
JP4390809B2 (en) * 2004-01-07 2009-12-24 イーエルシー マネージメント エルエルシー Cosmetic composition and method for hair growth retardation
JP5070434B2 (en) * 2004-01-16 2012-11-14 ビーエーエスエフ、ビューティー、ケア、ソルーションズ、フランス、エスエーエス Uses of extracts of the genus Calyceae
US20050249685A1 (en) * 2004-04-27 2005-11-10 Natalia Botchkareva Reduction of hair growth
WO2005123055A2 (en) * 2004-06-14 2005-12-29 Musc Foundation For Research Development Methods for treating inflammatory disorders
EP1811991B1 (en) 2004-11-10 2018-11-07 Genzyme Corporation Treatment of type 2 diabetes using inhibitors of glycosphingolipid synthesis
JP2008523159A (en) * 2004-12-22 2008-07-03 ザ ジレット コンパニー Reduction of hair growth by survivin inhibitor
WO2006069048A2 (en) * 2004-12-22 2006-06-29 The Gillette Company Reduction of hair growth
AU2005319138B2 (en) * 2004-12-22 2010-04-08 The Gillette Company Reduction of hair growth
US7618956B2 (en) * 2005-05-31 2009-11-17 The Gillette Company Reduction of hair growth
US20070059264A1 (en) * 2005-09-13 2007-03-15 Ahluwalia Gurpreet S Reduction of hair growth
US7727516B2 (en) * 2006-02-28 2010-06-01 The Procter & Gamble Company Reduction of hair growth
ES2546181T3 (en) 2006-05-09 2015-09-21 Genzyme Corporation Methods of treating fatty liver disease by inhibiting the synthesis of glycosphingolipids
EP2594564B1 (en) 2007-05-31 2016-09-28 Genzyme Corporation 2-acylaminopropanol-type glucosylceramide synthase inhibitors
KR20160085917A (en) 2007-10-05 2016-07-18 젠자임 코포레이션 Method of treating polycystic kidney diseases with ceramide derivatives
WO2009132082A2 (en) * 2008-04-22 2009-10-29 Medical College Of Georgia Research Institute, Inc. Immunogenic compositions containing ceramide and methods of use thereof
US8389517B2 (en) 2008-07-28 2013-03-05 Genzyme Corporation Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular disease
CN102271678B (en) 2008-10-03 2017-06-30 简詹姆公司 2 acylaminopropoanol-type glucosylceramide synthase inhibitors
MX2012009637A (en) * 2010-02-17 2012-09-12 Procter & Gamble Efficacious depilatory article.
ES2379703T3 (en) * 2010-03-26 2012-04-30 The Procter And Gamble Company Hair removal method and hair removal kit
WO2011119557A2 (en) * 2010-03-26 2011-09-29 The Procter & Gamble Company Kit and method for removing hair
KR20150091983A (en) * 2014-02-04 2015-08-12 (주)네오팜 Composition for preventing hair loss or promoting hair growth
WO2017165313A1 (en) 2016-03-25 2017-09-28 Aminex Therapeutics Inc. Bioavailable polyamines
WO2019018185A1 (en) 2017-07-15 2019-01-24 Arisan Therapeutics Inc. Enantiomerically pure adamantane derivatives for the treatment of filovirus infection
WO2019236722A1 (en) * 2018-06-05 2019-12-12 Chatterjee Subroto B Inhibitors of glycosphingolipid synthesis and methods of use
AU2021354039A1 (en) 2020-09-30 2023-05-25 Aminex Therapeutics, Inc. Combination drug substance of polyamine transport inhibitor and dfmo

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3426137A (en) * 1965-12-23 1969-02-04 Olin Mathieson Hair growth inhibiting by aminobenzophenones
US4161540A (en) * 1966-08-22 1979-07-17 Schering Corporation Antiandrogenic agents and methods for the treatment of androgen dependent disease states
GB1458349A (en) * 1972-12-05 1976-12-15 Sykora F Composition for and a process therewith of treating the hair and/or scalps of animals
US4039669A (en) * 1975-08-01 1977-08-02 Sterling Drug Inc. Composition for topical application and use thereof
US4139638A (en) * 1976-09-23 1979-02-13 Schering Corporation Methods for the treatment of hirsutism
FR2380775A1 (en) * 1977-02-22 1978-09-15 Sederma Sarl "AFTER-DEPILATION" COMPOSITION PROMOTING A PROGRESSIVE SLOWING OF HAIR REGROWTH
US4191775A (en) * 1977-12-15 1980-03-04 Imperial Chemical Industries Limited Amide derivatives
US4269831A (en) * 1979-05-09 1981-05-26 Sterling Drug Inc. Topical dermatological method of use of an androstenopyrazole
US4439432A (en) * 1982-03-22 1984-03-27 Peat Raymond F Treatment of progesterone deficiency and related conditions with a stable composition of progesterone and tocopherols
JP2519024B2 (en) * 1982-06-07 1996-07-31 花王株式会社 Hair cosmetics
US4508714A (en) * 1983-11-14 1985-04-02 Tihomir Cecic Organic scalp lotion
US4885289A (en) * 1983-12-12 1989-12-05 Breuer Miklos M Alteration of character of male beard growth
US4720489A (en) * 1984-10-15 1988-01-19 Douglas Shander Hair growth modification with ornithine decarboxylase inhibitors
US4935231A (en) * 1985-08-28 1990-06-19 Repligen Corporation Use of thioredoxin, thioredoxin-derived, or thioredoxin-like dithiol peptides in hair care preparations
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
DE3871974T2 (en) * 1987-02-12 1993-01-14 Estee Lauder Inc HAIR PROTECTIVE AGENT AND METHOD.
GB9009793D0 (en) * 1990-05-01 1990-06-20 Unilever Plc Cosmetic composition
US5096911A (en) 1990-06-25 1992-03-17 Ahluwalia Gurpreet S Alteration of rate and character of hair growth
ES2109949T3 (en) 1990-08-14 1998-02-01 Joseph H Handelman ENZYMATIC ALTERATION OF HAIR GROWTH.
US5189212A (en) 1990-09-07 1993-02-23 University Of Georgia Research Foundation, Inc. Triarylethylene carboxylic acids with estrogenic activity
US5095007A (en) 1990-10-24 1992-03-10 Ahluwalia Gurpreet S Alteration of rate and character of hair growth
DE4038693A1 (en) 1990-12-05 1992-06-11 Heverhagen Ulrich MEANS TO REDUCE GROWTH OR TO REMOVE HAIR ON HUMAN BODY
US5143925A (en) 1990-12-20 1992-09-01 Douglas Shander Alteration of rate and character of hair growth
GB9118866D0 (en) * 1991-09-04 1991-10-23 Unilever Plc Cosmetic composition
GB9118979D0 (en) 1991-09-04 1991-10-23 Unilever Plc Cosmetic composition
US5328686A (en) 1991-10-30 1994-07-12 Douglas Shander Treatment of acne or of pseudofolliculitis barbae
JPH07504646A (en) 1991-11-05 1995-05-25 ザ、ジレット、カンパニー Changes in the speed and characteristics of hair growth
US5364885A (en) 1992-11-13 1994-11-15 Ahluwalia Gurpreet S Reduction of hair growth
US5411991A (en) 1992-12-22 1995-05-02 Shander; Douglas Method of reducing hair growth employing sulfhydryl active compounds
US5648394A (en) 1993-05-27 1997-07-15 Boxall; Brian Alfred Topical composition for inhibiting hair growth
US5362748A (en) 1993-09-15 1994-11-08 The Procter & Gamble Company Methods of using diethyldithiocarbamic acid for the prevention of hair growth
AU1315095A (en) * 1993-12-17 1995-07-03 Unilever Plc Synthetic ceramides and their use in cosmetic compositions
US5474763A (en) 1994-03-11 1995-12-12 Shander; Douglas Reduction of hair growth
US5455234A (en) 1994-03-16 1995-10-03 Ahluwalia; Gurpreet S. Inhibition of hair growth
US5468476A (en) 1994-03-16 1995-11-21 Ahluwalia; Gurpreet S. Reduction of hair growth
FR2718961B1 (en) * 1994-04-22 1996-06-21 Oreal Compositions for washing and treating hair and skin based on ceramide and polymers with cationic groups.
FR2719216B1 (en) * 1994-05-02 1996-05-31 Oreal Composition for the treatment and protection of hair based on ceramides and vinylpyrrolidone polymers.
US5554608A (en) 1994-09-28 1996-09-10 Ahluwalia; Gurpreet S. Inhibition of hair growth
US5674477A (en) 1995-02-28 1997-10-07 Ahluwalia; Gurpreet S. Reduction of hair growth
US5645825A (en) 1995-06-07 1997-07-08 The Procter & Gamble Company Depilatory compositions comprising sulfhydryl compounds
DE19523479C1 (en) * 1995-06-28 1996-10-10 Henkel Kgaa Synthetic ceramide barrier lipid cpds. for use in skin or hair care prods. e.g. moisturising agents
US5728736A (en) 1995-11-29 1998-03-17 Shander; Douglas Reduction of hair growth
US5652273A (en) 1995-11-30 1997-07-29 Henry; James Reduction of hair growth
DK0996409T3 (en) * 1996-07-12 2003-08-11 Johnson & Johnson Consumer Preparation to delay hair growth and similar use
US5908867A (en) 1996-07-18 1999-06-01 Henry; James P. Reduction of hair growth
US5840752A (en) 1996-11-21 1998-11-24 Henry; James P. Reduction of hair growth
ZA9711121B (en) 1996-12-13 1998-06-23 Handelman Joseph H Reduction of hair growth.
US6037326A (en) 1996-12-31 2000-03-14 Styczynski; Peter Reduction of hair growth
US5939458A (en) 1997-09-22 1999-08-17 Henry; James P. Reduction of hair growth
US5958946A (en) 1998-01-20 1999-09-28 Styczynski; Peter Modulation of hair growth
US6020006A (en) 1998-10-27 2000-02-01 The Gillette Company Reduction of hair growth
US6489291B1 (en) * 1999-10-05 2002-12-03 Kao Corporation Topical composition for skin

Also Published As

Publication number Publication date
DE60130735T2 (en) 2008-07-17
WO2001054654A3 (en) 2002-02-21
EP1250119B1 (en) 2007-10-03
MXPA02005091A (en) 2002-11-07
ES2290151T3 (en) 2008-02-16
EP1250119A2 (en) 2002-10-23
CA2385006A1 (en) 2001-08-02
CA2385006C (en) 2006-09-12
AR028498A1 (en) 2003-05-14
WO2001054654A2 (en) 2001-08-02
DE60130735D1 (en) 2007-11-15
US6235737B1 (en) 2001-05-22
ATE374643T1 (en) 2007-10-15

Similar Documents

Publication Publication Date Title
AU2001229712A1 (en) Reduction of hair growth
EP1291377B8 (en) Silicone compound and cosmetic preparation
AU4466901A (en) Hair growth or hair formation controlling agents
ZA986822B (en) Reduction of hair growth
AU2001244731A1 (en) Hair growth stimulant compositions
AU2002309036A1 (en) Preparation for hair and/or scalp
AU2001284417A1 (en) Hair growth stimulants
AU9319798A (en) Reduction of hair growth
AU2001247600A1 (en) Methods of modulating hair growth
AU2004226467A8 (en) Reduction of hair growth
AU5647601A (en) Hair treatment compositions
AU2001273972A1 (en) Hair treatment composition
AU2001288093A1 (en) Hair growth stimulant
AU2001244729A1 (en) Hair growth stimulant compositions
AU2001264863A1 (en) Preparation of fagopyritols and uses therefor
AU2003245262A1 (en) Reduction of hair growth
AU2002224178A1 (en) Use of cyclosporin 7-thioamide derivatives for hair growth
AU2000274825A1 (en) Cosmetic method
AU2001274080A1 (en) Regulation of human transketolase-like enzyme
AU2002223679A1 (en) Hair treatment composition
AU2001287674A1 (en) Hair treatment compositions
AU2000245998A1 (en) Beauty pillow
AU2001263926A1 (en) Hair treatment compositions
AU2001253560A1 (en) Methods of treatment
AU2001258330A1 (en) New uses of imidazolylmethyl-pyridines